相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulation
Gorka Gerenu et al.
MOLECULAR PSYCHIATRY (2021)
Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
Jing Qian et al.
NEUROLOGY (2021)
Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
Jing Qian et al.
NEUROLOGY (2021)
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease
Courtney M. Kloske et al.
FRONTIERS IN IMMUNOLOGY (2020)
Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Na Zhao et al.
NEURON (2020)
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
Ranl Loera-Valencia et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Patricia Regina Manzine et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Understanding the Role of Systemic Inflammation in Alzheimer's Disease
Keenan A. Walker et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
Ruth Stephen et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
Anna Rosenberg et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study
Nina Kemppainen et al.
NEUROLOGY (2018)
Targeting Alzheimer's disease with gene and cell therapies
R. Loera-Valencia et al.
JOURNAL OF INTERNAL MEDICINE (2018)
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types
Yuan-Ta Lin et al.
NEURON (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Luigi Ferrucci et al.
NATURE REVIEWS CARDIOLOGY (2018)
Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
Ruth Stephen et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The role of APOE on lipid homeostasis and inflammation in normal brains
G. William Rebeck
JOURNAL OF LIPID RESEARCH (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
Midlife systemic inflammatory markers are associated with late-life brain volume The ARIC study
Keenan A. Walker et al.
NEUROLOGY (2017)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu et al.
NEURON (2017)
Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
Patricia Rodriguez-Rodriguez et al.
BRAIN (2017)
Human Plasma Thioredoxin-80 Increases With Age and in ApoE-/- Mice Induces Inflammation, Angiogenesis, and Atherosclerosis
Dominique Couchie et al.
CIRCULATION (2017)
Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease
Ben Shackleton et al.
CURRENT ALZHEIMER RESEARCH (2017)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2016)
Differential diagnosis of neurodegenerative diseases using structural MRI data
Juha Koikkalainen et al.
NEUROIMAGE-CLINICAL (2016)
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
Clifford R. Jack et al.
BRAIN (2015)
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Tiia Ngandu et al.
LANCET (2015)
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
Daniel M. Michaelson
ALZHEIMERS & DEMENTIA (2014)
ADAM10 in Synaptic Physiology and Pathology
Stefano Musardo et al.
NEURODEGENERATIVE DISEASES (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-A Randomized Controlled Lifestyle Trial
Tiia Ngandu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2014)
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress
Miia Kivipelto et al.
ALZHEIMERS & DEMENTIA (2013)
Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis
Dler Faieeq Darweesh Mahmood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
Francisco Gil-Bea et al.
EMBO MOLECULAR MEDICINE (2012)
Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts
Yanbo Wang et al.
NEUROIMAGE (2012)
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens
Ximena Cortes-Bratti et al.
PLOS ONE (2011)
Expression and extracellular release of Trx80, the truncated form of thioredoxin, by TNF-α- and IL-1β-stimulated human synoviocytes from patients with rheumatoid arthritis
Herve Lemarechal et al.
CLINICAL SCIENCE (2007)
Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages
Laia Jofre-Monseny et al.
BRITISH JOURNAL OF NUTRITION (2007)
Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease
S. Akterin et al.
CELL DEATH AND DIFFERENTIATION (2006)
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
Miia Kivipelto et al.
LANCET NEUROLOGY (2006)
Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK
K Pekkari et al.
BLOOD (2005)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Truncated thioredoxin (Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxido-reductase activity
K Pekkari et al.
FEBS LETTERS (2003)
α- and β-secretase:: profound changes in Alzheimer's disease
SJ Tyler et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes
K Pekkari et al.
BLOOD (2001)
Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma
K Pekkari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Physiological functions of thioredoxin and thioredoxin reductase
ESJ Arnér et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
